I’m trying to decide which stock would be the better buy right now: Novo Nordisk or Eli Lilly. Novo has dropped significantly from its previous highs, giving potential value opportunities with a low P/E ratio and dividends, but it will have its challenges like less demand for its weight-loss drugs and growing competition. Eli Lilly has promising new weight-loss treatments showing strong trial results, which could drive growth. I am trying to weigh Novo’s stability against Lilly’s growth potential before making a decision on what to buy this week. Thanks!
Posted by Cocomarie1234
1 Comment
LLY is down from its ATH by quite a bit even after meeting earnings. Could be some volatility in the near future before it stabilizes and goes on any kind of growth trend again